News

Zacks Investment Research on MSN2d
Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?
Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...
Eli Lilly's Omvoh wins Health Canada approval for Crohn’s disease
Eli Lilly (LLY) has won Health Canada approval for Omvoh (mirikizumab) in patients with Crohn’s disease, the company said on ...
Cantech Letter4d
Health Canada Approves Lilly’s Omvoh® (mirikizumab) for Crohn’s Disease; New Citrate-Free Formulation
Omvoh® is now indicated for both major forms of Inflammatory Bowel Disease (IBD) – ulcerative colitis (UC) and Crohn’s ...